PASI Improvement in the First 12 Weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials. J of Skin 2023, 7 (6), s237. https://doi.org/10.25251/skin.7.supp.237.